A look at why pill-form peptides work even though only a small share of each dose gets absorbed by the body.
Recap by typeshit. Full story at Miami Herald on MSN.
Weight loss may explain much of the knee benefit, but lab work hints at anti-inflammatory and cartilage effects worth a closer read.
A new GLP-1 described as stronger than current options is being tested in trials, and researchers lay out what people should understand about it.
A SURPASS-4 analysis at ASN Kidney Week 2026 found rapid kidney decline in 5% on tirzepatide versus 13% on insulin glargine, with the biggest gains in high protein groups.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
An explainer on pill-form peptide drugs, noting that only a small share of each dose actually gets absorbed by the body.
A short post noting that Ozempic can bring nausea, heartburn and vomiting, and that some foods may make these GI effects worse.
Loading…